Biochemical analysis of α-synuclein extracted from control and Parkinson's disease colonic biopsies

Neuroscience Letters

Volumn 641, Issue , 2017, Pages 81-86

  Corbillé, Anne Gaëlle ^a,b,c   Preterre, Cécile ^a,b,c   Rolli Derkinderen, Malvyne ^a,b,c   Coron, Emmanuel ^a,b,c   Neunlist, Michel ^a,b,c   Lebouvier, Thibaud ^d   Derkinderen, Pascal ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d Centre Memoire de Ressources et de Recherche (CMRR)   (France)

Author keywords

Alpha synuclein; Enteric nervous system; Gastrointestinal biopsy; Phosphorylation; Two dimensional immunoblot; Western blot

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; ARTICLE; BIOCHEMICAL ANALYSIS; BRAIN BIOPSY; CLINICAL ARTICLE; COLON BIOPSY; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DISEASE DURATION; FEMALE; GASTROINTESTINAL BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGMOIDOSCOPY; TEMPORAL CORTEX; TWO DIMENSIONAL ELECTROPHORESIS; BIOPSY; CASE CONTROL STUDY; CHEMISTRY; COLON;

AGED; ALPHA-SYNUCLEIN; BIOPSY; CASE-CONTROL STUDIES; COLON; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 85010841176     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2017.01.050     Document Type: Article

References (38)

1. [1] Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M., Goedert, M., Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 95 (1998), 6469–6473.
2. [2] Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M.S., et al. Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4 (2002), 160–164.
3. [3] Anderson, J.P., Walker, D.E., Goldstein, J.M., de Laat, R., Banducci, K., Caccavello, R.J., et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281 (2006), 29739–29752.
4. [4] Beach, T.G., Adler, C.H., Sue, L.I., Vedders, L., Lue, L., White Iii, C.L., et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 119 (2010), 689–702.
5. [5] Beach, T.G., Corbillé, A.-G., Letournel, F., Kordower, J.H., Kremer, T., Munoz, D.G., et al. Multicenter assessment of immunohistochemical methods for pathological alpha-Synuclein in sigmoid colon of autopsied parkinson's disease and control subjects. J. Parkinson's Dis. 6 (2016), 761–770.
6. [6] Lebouvier, T., Chaumette, T., Damier, P., Coron, E., Touchefeu, Y., Vrignaud, S., et al. Pathological lesions in colonic biopsies during Parkinson's disease. Gut 57 (2008), 1741–1743, 10.1136/gut.2008.162503.
7. [7] Lebouvier, T., Neunlist, M., Bruley des Varannes, S., Coron, E., Drouard, A., Nguyen, J.-M., et al. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One, 5, 2010, e12728.
8. [8] Pouclet, H., Lebouvier, T., Coron, E., des Varannes, S.B., Rouaud, T., Roy, M., et al. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease. Neurobiol. Dis. 45 (2012), 305–309.
9. [9] Visanji, N.P., Marras, C., Kern, D.S., Al Dakheel, A., Gao, A., Liu, L.W.C., et al. Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease. Neurology 84 (2015), 609–616.
10. [10] Shannon, K.M., Keshavarzian, A., Mutlu, E., Dodiya, H.B., Daian, D., Jaglin, J.A., et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov. Disord. 27 (2012), 709–715.
11. [11] Hilton, D., Stephens, M., Kirk, L., Edwards, P., Potter, R., Zajicek, J., et al. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol. 127 (2013), 235–241.
12. [12] Corbillé, A.-G., Letournel, F., Kordower, J.H., Lee, J., Shanes, E., Neunlist, M., et al. Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies. Acta Neuropathol. Commun., 4, 2016, 35.
13. [13] Preterre, C., Corbillé, A.-G., Balloy, G., Letournel, F., Neunlist, M., Derkinderen, P., Optimizing western blots for the detection of endogenous α-synuclein in the enteric nervous system. J, Parkinson's Dis. 5 (2015), 765–772.
14. [14] Newman, A.J., Selkoe, D., Dettmer, U., A new method for quantitative immunoblotting of endogenous α-synuclein. PLoS One, 8, 2013, e81314.
15. [15] Li, Q.-X., Campbell, B.C.V., McLean, C.A., Thyagarajan, D., Gai, W.P., Kapsa, R.M., et al. Platelet alpha- and gamma-synucleins in Parkinson's disease and normal control subjects. J. Alzheimers Dis. 4 (2002), 309–315.
16. [16] Borghi, R., Marchese, R., Negro, A., Marinelli, L., Forloni, G., Zaccheo, D., et al. Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci. Lett. 287 (2000), 65–67.
17. [17] Wang, W., Nguyen, L.T.T., Burlak, C., Chegini, F., Guo, F., Chataway, T., et al. Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 9587–9592.
18. [18] Braak, H., Del Tredici, K., Rüb, U., de Vos, R.A.I., Jansen Steur, E.N.H., Braak, E., Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24 (2003), 197–211.
19. [19] Braak, H., de Vos, R.A.I., Bohl, J., Del Tredici, K., Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach‘s plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci. Lett. 396 (2006), 67–72.
20. [20] Braak, H., Del Tredici, K., Potential pathways of abnormal tau and α-synuclein dissemination in sporadic alzheimers and parkinsons diseases. Cold Spring Harb. Perspect. Biol., 8, 2016, a023630, 10.1101/cshperspect.a023630.
21. [21] Brundin, P., Ma, J., Kordower, J.H., How strong is the evidence that Parkinson's disease is a prion disorder?. Curr. Opin. Neurol. 29 (2016), 459–466.
22. [22] Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 128 (2014), 805–820.
23. [23] Rey, N.L., Steiner, J.A., Maroof, N., Luk, K.C., Madaj, Z., Trojanowski, J.Q., et al. Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease. J. Exp. Med. 213 (2016), 1759–17784.
24. [24] Lebouvier, T., Tasselli, M., Paillusson, S., Pouclet, H., Neunlist, M., Derkinderen, P., Biopsable neural tissues: toward new biomarkers for Parkinson's disease?. Front. Psychiatry, 1, 2010, 128.
25. [25] Lee, J.M., Derkinderen, P., Kordower, J.H., Freeman, R., Munoz, D.G., Kremer, T., et al. The search for a peripheral biopsy indicator of α-Synuclein pathology for parkinson disease. J. Neuropathol. Exp. Neurol., 2017, nlw103, 10.1093/jnen/nlw103.
26. [26] Duda, J.E., Shah, U., Arnold, S.E., Lee, V.M., Trojanowski, J.Q., The expression of alpha- beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Exp. Neurol. 160 (1999), 515–522.
27. [27] Arnold, S.E., Lee, E.B., Moberg, P.J., Stutzbach, L., Kazi, H., Han, L.-Y., et al. Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease. Ann. Neurol. 67 (2010), 462–469.
28. [28] Saito, Y., Shioya, A., Sano, T., Sumikura, H., Murata, M., Murayama, S., Lewy body pathology involves the olfactory cells in Parkinson's disease and related disorders. Mov. Disord. 31 (2016), 135–138.
29. [29] Funabe, S., Takao, M., Saito, Y., Hatsuta, H., Sugiyama, M., Ito, S., et al. Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa. Neuropathology 33 (2013), 47–58.
30. [30] Witt, M., Bormann, K., Gudziol, V., Pehlke, K., Barth, K., Minovi, A., et al. Biopsies of olfactory epithelium in patients with Parkinson's disease. Mov. Disord. 24 (2009), 906–914.
31. [31] Corbillé, A.-G., Clairembault, T., Coron, E., Leclair-Visonneau, L., Preterre, C., Neunlist, M., et al. What a gastrointestinal biopsy can tell us about Parkinson's disease. Neurogastroenterol. Motil. 28 (2016), 966–974.
32. [32] Lee, B.R., Kamitani, T., Improved immunodetection of endogenous α-synuclein. PLoS One, 6, 2011, e23939.
33. [33] Böttner, M., Zorenkov, D., Hellwig, I., Barrenschee, M., Harde, J., Fricke, T., et al. Expression pattern and localization of alpha-synuclein in the human enteric nervous system. Neurobiol. Dis. 48 (2012), 474–480.
34. [34] Barrenschee, M., Zorenkov, D., Böttner, M., Lange, C., Cossais, F., Scharf, A.B., et al. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease. Acta Neuropathol. Commun., 5, 2017, 1.
35. [35] Pouclet, H., Lebouvier, T., Coron, E., des Varannes, S.B., Neunlist, M., Derkinderen, P., A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease. Neurogastroenterol. Motil. 24 (2012), e202–5.
36. [36] Hirai, Y., Fujita, S.C., Iwatsubo, T., Hasegawa, M., Phosphorylated alpha-synuclein in normal mouse brain. FEBS Lett. 572 (2004), 227–232.
37. [37] Fairfoul, G., McGuire, L.I., Pal, S., Ironside, J.W., Neumann, J., Christie, S., et al. Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann. Clin. Transl. Neurol. 3 (2016), 812–818.
38. [38] Shahnawaz, M., Tokuda, T., Waragai, M., Mendez, N., Ishii, R., Trenkwalder, C., et al. Development of a biochemical diagnosis of parkinson disease by detection of α-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol., 2016, 10.1001/jamaneurol.2016.4547.